All Pharma News
Positive Results In The Interim Analysis Of The Trial Of Recbio`s Vaccine REC610

Positive Results In The Interim Analysis Of The Trial Of Recbio`s Vaccine REC610
PR NEWSWIRE
28 Dec 2023
Share Share
Jiangsu Recbio Technology Co., Ltd. announced 2023 interim results report

Jiangsu Recbio Technology Co., Ltd. announced 2023 interim results report
PR NEWSWIRE
27 Aug 2023
Share Share
Acceptance of Clinical Trial Application For The Recbio`s Vaccine REC610

Acceptance of Clinical Trial Application For The Recbio`s Vaccine REC610
PR NEWSWIRE
26 Jul 2023
Share Share
Two-Component Recombinant COVID-19 Vaccine ReCOV Granted With EUA

Two-Component Recombinant COVID-19 Vaccine ReCOV Granted With EUA
PR NEWSWIRE
21 Mar 2023
Share Share
Clinical Trial Approval For The Company`s Novel Vaccine REC610

Clinical Trial Approval For The Company`s Novel Vaccine REC610
PRNEWSWIRE
19 Dec 2022
Share Share
Superior Results Of The Comparative Study Of Recombinant COVID-19 Vaccine ReCOV

Superior Results Of The Comparative Study Of Recombinant COVID-19 Vaccine ReCOV
PRNEWSWIRE
14 Dec 2022
Share Share
Jiangsu Recbio Increases Production For First Phase Of Manufacturing Facility

Jiangsu Recbio Increases Production For First Phase Of Manufacturing Facility
PRNEWSWIRE
21 Nov 2022
Share Share
Recbio taps OCT Clinical for COVID-19 vaccine trial

Recbio taps OCT Clinical for COVID-19 vaccine trial
Joseph Keenan FIERCEBIOTECH
13 Sep 2022
Share Share
Recbio Announces Interim results for the Fiscal Year 2022 and Company Progress

Recbio Announces Interim results for the Fiscal Year 2022 and Company Progress
PRNEWSWIRE
29 Aug 2022
Share Share
Completion Of Subject Enrollment And Vaccination For ReCOV And mRNA Vaccines

Completion Of Subject Enrollment And Vaccination For ReCOV And mRNA Vaccines
PRNEWSWIRE
18 Aug 2022
Share Share